Healthcare

Lender RND Funding wants to revise its case against BDO Advisory and auditor Ernst & Young over advice given to defunct Adelaide company Gen1 Biotechnology, a week out from trial.

Shine Lawyers has won a 12-month extension to serve class actions three against drug companies that sell proton pump inhibitors.

The National Cancer Foundation has defeated a challenge to its Brown Nose Day trade mark used for bowel cancer fundraising, with the Full Court finding it is not deceptively similar to SIDS Kids’ Red Nose Day mark. 

The Queensland government has used special powers to approve a major mixed-used development surrounding the Dreamworld theme park, paving the way for new resorts and residential and commercial developments.

The Australian Competition and Consumer Commission has opened a phase 2 review into animal drug company Zoetis' proposed acquisition of Neogen's global animal genomic testing business, saying it would substantially lessen competition in the market for animal gene testing services.

US drug maker Cosette wants to strike out Mayne Pharma's causation pleading in its suit seeking damages after Cosette allegedly inducing the treasurer to reject their $672 million tie-up.

A class action against Johnson & Johnson over alleged ineffective cold medicine has attacked the pharmaceutical company’s application for soft class closure, telling a court the process would produce useless data and only need to be repeated. 

Swiss drug maker Novartis has lost its bid to have Pharmacor's Valtresto trade mark removed for non use, with an IP Australia delegate finding that an injunction in a fight over the patent for Novartis' heart drug Entresto was an obstacle to using the mark. 

Real estate fund manager Charter Hall Group has added to its social infrastructure portfolio with the $445 million acquisition of Sonic Healthcare's major pathology facility in the Brisbane CBD.

Oral care company Hismile has paid $138,600 in penalties after the consumer watchdog issued it with seven infringement notices over alleged false and misleading social media advertisements.